0000000000284235
AUTHOR
O. Casasnovas
STEM CELL COLLECTION AFTER FAILURE OF UPFRONT ABVD OR BEACOPP IN PATIENTS WITH HIGH RISK ADVANCED STAGE III-IV HODGKIN'S LYMPHOMA
Overall survival impact of BEACOPP versus ABVD in advanced hodgkin lymphoma: a pooled analysis of 4 randomized trials
IF 6.671; International audience
Deauville score evaluationof PET2 positive patients included in the H10 trial
IF 7.704 (2017)Communication donnée lors du 31st Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Dusseldorf, Germany, du 13 au 17 octobre 2018; International audience